Status
Conditions
Treatments
About
A multicentre prospective cohort study will monitor the efficacy and safety of Autologous Fat Transfer (AFT) with pre-expansion. AFT will be evaluated in terms of quality of life, aesthetic result, complications, oncological safety and cost-effectiveness. It follows the BREAST trial, the randomised controlled trial comparing AFT with implant-based reconstruction. In this study, patients all receive AFT.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
350 participants in 1 patient group
Loading...
Central trial contact
Jamilla Wederfoort, MD, MSc
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal